1. Home
  2. SABS vs GWAV Comparison

SABS vs GWAV Comparison

Compare SABS & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • GWAV
  • Stock Information
  • Founded
  • SABS 2014
  • GWAV 2002
  • Country
  • SABS United States
  • GWAV United States
  • Employees
  • SABS N/A
  • GWAV N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • GWAV Packaged Foods
  • Sector
  • SABS Health Care
  • GWAV Consumer Staples
  • Exchange
  • SABS Nasdaq
  • GWAV Nasdaq
  • Market Cap
  • SABS 11.4M
  • GWAV 11.5M
  • IPO Year
  • SABS N/A
  • GWAV N/A
  • Fundamental
  • Price
  • SABS $1.37
  • GWAV $0.16
  • Analyst Decision
  • SABS Strong Buy
  • GWAV
  • Analyst Count
  • SABS 5
  • GWAV 0
  • Target Price
  • SABS $11.40
  • GWAV N/A
  • AVG Volume (30 Days)
  • SABS 25.6K
  • GWAV 4.7M
  • Earning Date
  • SABS 05-19-2025
  • GWAV 05-19-2025
  • Dividend Yield
  • SABS N/A
  • GWAV N/A
  • EPS Growth
  • SABS N/A
  • GWAV N/A
  • EPS
  • SABS N/A
  • GWAV N/A
  • Revenue
  • SABS $1,322,410.00
  • GWAV $33,315,859.00
  • Revenue This Year
  • SABS N/A
  • GWAV N/A
  • Revenue Next Year
  • SABS $50.00
  • GWAV N/A
  • P/E Ratio
  • SABS N/A
  • GWAV N/A
  • Revenue Growth
  • SABS N/A
  • GWAV N/A
  • 52 Week Low
  • SABS $1.00
  • GWAV $0.12
  • 52 Week High
  • SABS $5.01
  • GWAV $44.55
  • Technical
  • Relative Strength Index (RSI)
  • SABS 46.90
  • GWAV 36.08
  • Support Level
  • SABS $1.30
  • GWAV $0.12
  • Resistance Level
  • SABS $1.49
  • GWAV $0.20
  • Average True Range (ATR)
  • SABS 0.13
  • GWAV 0.04
  • MACD
  • SABS 0.04
  • GWAV -0.00
  • Stochastic Oscillator
  • SABS 75.51
  • GWAV 31.01

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company's products are selling ferrous metal, which is used in the recycling and production of finished steel. It is categorized into heavy melting steel, plate and structural, and shredded scrap. and it also processes nonferrous metals such as aluminum, copper, stainless steel, nickel, brass, titanium, alloys, and mixed metal products.

Share on Social Networks: